Hypothyroidism Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017

Hypothyroidism Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017

  • November 2017 •
  • 152 pages •
  • Report ID: 5184165 •
  • Format: PDF
Hypothyroidism is a thyroid disorder where thyroid gland secretes less triiodothyronine (T3) and thyroxine (T4) inadequate to meet peripheral tissue demand. To compensate the decline in T3 and T4 levels, thyroid stimulating hormone (TSH) is produced in the pituitary gland.

These hormones regulate metabolism in the body and irregular secretion leads to disturbances in metabolism and energy storage. Further, normal functioning of brain, heart, muscles, and other organs can also be affected.

Auto-immune diseases, thyroidectomy, radiotherapy, radioiodine thyroid ablation typically cause hypothyroidism. The condition is common among women and old population.

-Primary hypothyroidism – caused by disease to thyroid gland itself and is the most common cause of hypothyroidism.
- Secondary hypothyroidism- dysfunction of pituitary gland or hypothalamus

Drugs- Levothyroxine (synthetic T4) is the most commonly prescribed drug

Hypothyroidism clinical trials report from VPA Research provides comprehensive analysis and trends in global Hypothyroidism disease clinical trials. The research work analyzes the evolution of Hypothyroidism clinical trial trends across countries and regions.

The report focuses on drugs and therapies being evaluated for Hypothyroidism treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner offering quick access to Hypothyroidism clinical trials.

Major drugs under development in Hypothyroidism are provided in the report along with their details of Mechanism of Action, Route of Administration, Target, therapy, molecule and class.

Scope of the Report-
- Number of Hypothyroidism clinical trials across regions- Asia and Oceania, Europe, Middle East Africa and Americas
- Trial information by Phase and Subjects recruited
- Trial information by status, type, sponsor type
- Drugs used for treatment of Hypothyroidism
- Both observational and interventional trials analyzed
- Success rates of trials are analyzed
- Trends in enrollment over the past ten years identified
- Leading sponsors of Hypothyroidism clinical trials worldwide are listed

Reasons to Buy-
- Track competition and design competitive advantages
- Identify right partners to associate with for further research
- Evaluate potential opportunities available in further clinical trials of the disease
- Formulate business development strategies through success rates of clinical trials
- Identify quick markets for recruiting subjects based on trials count by each market

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.